Drug Resistance after Failure of Initial Antiretroviral Therapy in Resource-Limited Countries
- 1 February 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 44 (3) , 453-455
- https://doi.org/10.1086/510752
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Options for a Second-Line Antiretroviral Regimen for HIV Type 1-Infected Patients Whose Initial Regimen of a Fixed-Dose Combination of Stavudine, Lamivudine, and Nevirapine FailsClinical Infectious Diseases, 2007
- A Pilot Study of Switch to Lopinavir/Ritonavir (LPV/r) Monotherapy from Nonnucleoside Reverse Transcriptase Inhibitor–Based TherapyHIV Research & Clinical Practice, 2006
- Lopinavir/Ritonavir as Single-Drug Therapy for Maintenance of HIV-1 Viral SuppressionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
- Lopinavir/ritonavir maintenance monotherapy after successful viral suppression with standard highly active antiretroviral therapy in HIV-1-infected patientsAIDS, 2005